{
  "company_number": "10509764",
  "name": "Northumbria Pharma Ltd",
  "url": "/company/10509764",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2016-12-05",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "21200",
      "description": "Manufacture of pharmaceutical preparations",
      "section": "C",
      "section_name": "Manufacturing",
      "url": "/sic/21200"
    }
  ],
  "registered_address": {
    "id": 2643319,
    "url": "/address/2643319",
    "line1": "NETPARK",
    "line2": "THOMAS WRIGHT WAY",
    "post_town": "SEDGEFIELD",
    "county": "COUNTY DURHAM",
    "country": "ENGLAND",
    "postcode": "TS21 3FD"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10509764",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-01-31",
    "last_made_up": "2025-04-30",
    "category": "FULL",
    "filings": [
      {
        "url": "/company/10509764/accounts/2025-04-30",
        "pdf_url": "/company/10509764/accounts/2025-04-30.pdf",
        "made_up_date": "2025-04-30",
        "period_start": "2024-05-01",
        "period_end": "2025-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "0.28",
        "tangible_fixed_assets": "1165858.00",
        "debtors": "21617650.00",
        "cash_bank_in_hand": "5330325.00",
        "current_assets": "38173104.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1116704.00",
        "total_assets_less_current_liabilities": "2282562.00",
        "net_assets_liabilities": "1720343.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "48000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": "2575931.00",
        "raw_materials_consumables": null,
        "staff_costs": "1532538.00",
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": "-29504.00",
        "tax_on_profit": "-40133.00",
        "profit_loss_for_period": "10629.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2026.zip"
      },
      {
        "url": "/company/10509764/accounts/2024-04-30",
        "pdf_url": "/company/10509764/accounts/2024-04-30.pdf",
        "made_up_date": "2024-04-30",
        "period_start": "2024-04-30",
        "period_end": "2024-04-30",
        "entity_name": "Northumbria Pharma Limited",
        "dormant": false,
        "average_employees": "23.00",
        "tangible_fixed_assets": "1313467.00",
        "debtors": "1528903.00",
        "cash_bank_in_hand": "1212351.00",
        "current_assets": "4661074.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1184125.00",
        "total_assets_less_current_liabilities": "2497592.00",
        "net_assets_liabilities": "1709714.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "48000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2025.zip"
      },
      {
        "url": "/company/10509764/accounts/2023-04-30",
        "pdf_url": "/company/10509764/accounts/2023-04-30.pdf",
        "made_up_date": "2023-04-30",
        "period_start": "2023-04-30",
        "period_end": "2023-04-30",
        "entity_name": "Northumbria Pharma Limited",
        "dormant": false,
        "average_employees": "29.00",
        "tangible_fixed_assets": "1459558.00",
        "debtors": "2252006.00",
        "cash_bank_in_hand": "905598.00",
        "current_assets": "6377857.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1107715.00",
        "total_assets_less_current_liabilities": "2567273.00",
        "net_assets_liabilities": "1594479.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "48000.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2024.zip"
      },
      {
        "url": "/company/10509764/accounts/2022-04-30",
        "pdf_url": "/company/10509764/accounts/2022-04-30.pdf",
        "made_up_date": "2022-04-30",
        "period_start": "2022-04-30",
        "period_end": "2022-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "25.00",
        "tangible_fixed_assets": "1079867.00",
        "debtors": "583690.00",
        "cash_bank_in_hand": "434429.00",
        "current_assets": "2534986.00",
        "creditors_due_within_one_year": "1493105.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1041881.00",
        "total_assets_less_current_liabilities": "2121748.00",
        "net_assets_liabilities": "1462775.00",
        "called_up_share_capital": "48000.00",
        "profit_loss_account_reserve": "1414775.00",
        "shareholder_funds": "1462775.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2023.zip"
      },
      {
        "url": "/company/10509764/accounts/2021-04-30",
        "pdf_url": "/company/10509764/accounts/2021-04-30.pdf",
        "made_up_date": "2021-04-30",
        "period_start": "2021-04-30",
        "period_end": "2021-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "16.00",
        "tangible_fixed_assets": "981381.00",
        "debtors": "1705840.00",
        "cash_bank_in_hand": "521463.00",
        "current_assets": "2846944.00",
        "creditors_due_within_one_year": "1569053.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1277891.00",
        "total_assets_less_current_liabilities": "2259272.00",
        "net_assets_liabilities": "1557953.00",
        "called_up_share_capital": "48000.00",
        "profit_loss_account_reserve": "1509953.00",
        "shareholder_funds": "1557953.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2022.zip"
      },
      {
        "url": "/company/10509764/accounts/2020-04-30",
        "pdf_url": "/company/10509764/accounts/2020-04-30.pdf",
        "made_up_date": "2020-04-30",
        "period_start": "2020-04-30",
        "period_end": "2020-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "11.00",
        "tangible_fixed_assets": "814731.00",
        "debtors": "1301784.00",
        "cash_bank_in_hand": "545399.00",
        "current_assets": "2037156.00",
        "creditors_due_within_one_year": "1461213.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "575943.00",
        "total_assets_less_current_liabilities": "1390674.00",
        "net_assets_liabilities": "1242042.00",
        "called_up_share_capital": "48000.00",
        "profit_loss_account_reserve": "1194042.00",
        "shareholder_funds": "1242042.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2021.zip"
      },
      {
        "url": "/company/10509764/accounts/2019-04-30",
        "pdf_url": "/company/10509764/accounts/2019-04-30.pdf",
        "made_up_date": "2019-04-30",
        "period_start": "2019-04-30",
        "period_end": "2019-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "792663.00",
        "debtors": "270667.00",
        "cash_bank_in_hand": "195124.00",
        "current_assets": "486936.00",
        "creditors_due_within_one_year": "357945.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "128991.00",
        "total_assets_less_current_liabilities": "921654.00",
        "net_assets_liabilities": "813315.00",
        "called_up_share_capital": "48000.00",
        "profit_loss_account_reserve": "765315.00",
        "shareholder_funds": "813315.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2020.zip"
      },
      {
        "url": "/company/10509764/accounts/2018-04-30",
        "pdf_url": "/company/10509764/accounts/2018-04-30.pdf",
        "made_up_date": "2018-04-30",
        "period_start": "2018-04-30",
        "period_end": "2018-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": false,
        "average_employees": "0.00",
        "tangible_fixed_assets": "280315.00",
        "debtors": "375889.00",
        "cash_bank_in_hand": "20814.00",
        "current_assets": "405005.00",
        "creditors_due_within_one_year": "125017.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "279988.00",
        "total_assets_less_current_liabilities": "560303.00",
        "net_assets_liabilities": "516545.00",
        "called_up_share_capital": "48000.00",
        "profit_loss_account_reserve": "468545.00",
        "shareholder_funds": "516545.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2019.zip"
      },
      {
        "url": "/company/10509764/accounts/2017-04-30",
        "pdf_url": "/company/10509764/accounts/2017-04-30.pdf",
        "made_up_date": "2017-04-30",
        "period_start": "2017-04-30",
        "period_end": "2017-04-30",
        "entity_name": "Northumbria Pharma Ltd",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "1.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "1.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2018.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10509764/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-09-01",
    "last_made_up": "2025-08-18"
  },
  "officers": [],
  "psc": [
    {
      "name": "Dr Samer Taslaq",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/4435101",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2017-07-17",
      "ceased_on": "2025-08-18",
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Mr Paul Watson",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3911812",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-50-to-75-percent",
        "voting-rights-50-to-75-percent"
      ],
      "notified_on": "2016-12-05",
      "ceased_on": "2025-08-18",
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Northumbria Pharma Group Holdings Ltd",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": "/company/16171886",
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent"
      ],
      "notified_on": "2025-08-18",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-14T22:54:55.161384+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}